Everything below concerns inert gas. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-07-30. Where a claim depends on a specific study, the study is described rather than over-claimed.
Shipping and short-term transfer require attention to temperature control and physical stability. Frozen solutions are commonly sent on dry ice, while lyophilized powders may travel with gel packs or insulated packaging. Thawing should be done slowly on ice or in a refrigerator, not by vigorous heating, and the solution should be mixed gently before use. Temperature loggers can document excursions during transit, but their presence does not prove that a peptide remained stable. Analytical checks such as chromatography or mass spectrometry can verify identity and purity after storage or shipping.
Reconstitution begins with selecting a solvent that dissolves the peptide without causing degradation. Water or aqueous buffer is suitable for many hydrophilic sequences, while hydrophobic peptides may require a small amount of organic solvent such as acetonitrile or dimethyl sulfoxide before dilution. The solvent is added to the vial rather than the powder being scraped out, and the mixture is swirled or inverted gently to avoid foaming. Complete dissolution should be confirmed visually, and insoluble material may indicate aggregation or impurities. Because solvent tolerance varies, published solubility information or a small test dissolution can guide handling.
Aseptic technique reduces microbial and particulate contamination when a peptide solution will be used in cell culture or other sensitive applications. Work in a clean area, use sterile containers and filtered tips, and avoid touching vial interiors. Preparing aliquots immediately after dissolution limits repeated temperature cycling, which is a common cause of aggregation and activity loss. Low-binding plastic tubes are preferred for peptides that adsorb to surfaces, especially hydrophobic or positively charged sequences. Labels should record identity, solvent, concentration, and preparation date so that later use can be traced.
Cold-chain practice relies on documented temperature ranges, calibrated monitoring, and minimized excursions. Shipments may use insulated boxes, phase-change materials, or dry ice, with data loggers to record conditions. Upon receipt, the recipient should verify the logger trace and place items into long-term storage promptly. Repeated warming and cooling during transfers can be more harmful than a single controlled excursion. For solutions, dividing material into single-use aliquots reduces the number of thawing and refreezing events and limits repeated opening of the same container.
Handling begins before a peptide arrives at the bench. Containers should be inspected for cracks, loose caps, or visible moisture, and labels should record identity, lot, and receipt date. Lyophilized material is often allowed to equilibrate to room temperature before opening to prevent condensation on the powder. Gloves and a clean workspace reduce contamination and static-related loss. Once opened, the vial may be purged with inert gas and resealed if the peptide is sensitive to oxygen or humidity. These steps are procedural safeguards rather than guarantees of stability.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized powder or frozen solution | Powder typically more stable for long-term storage; solutions require colder conditions. |
| Recommended reconstitution solvent | Water, buffer, or water-miscible organic solvent | Matches peptide hydrophobicity; test small portion if unknown. |
| Typical working aliquot size | Single-use volumes in low-binding tubes | Reduces repeated warming and cooling and contamination risk. |
| Short-term shipping condition | Dry ice for frozen solutions; gel packs for powders | Insulation and temperature logging help document transit. |
| Common purity check | Reverse-phase HPLC with UV detection | Often paired with mass spectrometry for identity confirmation. |
Reconstitution is often performed with sterile water, buffer, or a water-miscible organic solvent, depending on solubility. The solvent should be added gently along the vial wall, and the solution mixed by gentle swirling rather than vigorous vortexing, which can cause foaming and surface denaturation. Some sequences require a small amount of base or acid to dissolve, followed by pH adjustment. Preparing a concentrated stock solution can simplify later dilution, but the stock itself may have limited stability. Records of solvent, concentration, and date support reproducibility.
After reconstitution, dividing the solution into single-use aliquots limits multiple warming and cooling events and reduces contamination risk. Low-binding polypropylene tubes are often preferred because peptides can adsorb to glass or untreated plastic surfaces. Filling headspace with nitrogen or argon can slow oxidation, and amber or foil-wrapped containers reduce photodegradation. Each aliquot should be labeled with peptide identity, concentration, date, and storage conditions. Frozen aliquots should be thawed quickly and kept on ice until use.
When a peptide arrives, the vial should be inspected for damage, and its label, lot number, and accompanying analytical data should be recorded. Cold vials should equilibrate to room temperature before opening to prevent condensation on the powder. Moisture uptake can reduce stability and complicate accurate weighing or reconstitution. Inventory systems that track date, quantity, and storage location help prevent unnecessary temperature cycling. Personnel should follow institutional or manufacturer instructions for any specific peptide.
Receiving a peptide shipment requires immediate inspection of the packaging and temperature indicators. Any deviation from the specified cold chain should be documented and investigated. Upon arrival, solid peptides are generally kept at -20°C, whereas liquid formulations are stored at -80°C. Vials should be kept upright and protected from light. Repeated warming and cooling of the entire container is avoided by preparing smaller working aliquots. A log of lot numbers, receipt dates, and storage locations supports traceability and quality control.
Reconstitution is a critical handling step. The appropriate solvent—often sterile water, phosphate-buffered saline, or a water-acetonitrile mixture—is chosen based on peptide solubility. Adding solvent gently down the vial wall and swirling, rather than vortexing, reduces foaming and shear stress. The resulting solution should be clear; visible particles indicate incomplete dissolution or contamination. Concentration is recorded accurately because it affects subsequent use. If the peptide is not fully soluble, a small amount of organic solvent or a different buffer may be required, but this changes the final composition.
In this equation, the base (B) and the extremely strong base (the conjugate base OH−) compete for the proton. As a result, bases that react with water have relatively small equilibrium constant values. The base is weaker when it has a lower equilibrium constant value.
Masters had also done the same to buy himself a property. Several titles, including Accountancy Age and Computing were sold to the rival company VNU in 1980. The transaction raised £17m, half of which went to Heseltine, but in Crick's view was a bad move for Haymarket. During Heseltine's second period out of office (1986–1990), Masters threatened to resign if Heseltine returned to Haymarket, but once again he became a consultant on £100,000 per annum.
=== csARDs === Conventional synthetic antirheumatic drugs (csARDs) are a class of disease-modifying medications. Unlike biologics or targeted synthetic drugs, which act on specific pathways in the immune system, csARDs have a broader effect on the immune system and are often considered traditional or conventional treatments. The most common drugs in this class are methotrexate and sulfasalazine. These medications are only used when others fail, or when certain specific conditions are met, and are often discontinued if a patient's symptoms become manageable with just a TNFi or other medication. Conventional DMARDs such as leflunomide are also considered to be part of this class. Concerns exist about a possible lack of efficacy of some drugs in this class.
== Sources == This article incorporates text from a free content work. Licensed under CC BY 4.0. Text taken from The State of Food Security and Nutrition in the World 2024, FAO, IFAD, UNICEF, WFP and WHO, FAO. This article incorporates text from a free content work. Licensed under CC BY 4.0 (license statement/permission). Text taken from The State of Food Security and Nutrition in the World 2026, Food and Agriculture Organization of the United Nations.
In mid-2017, Wenger brought in two signings; Alexandre Lacazette for a fee of £45m, the club's most expensive signing, and Sead Kolašinac on a free transfer from Schalke 04. On 6 August, Wenger won his seventh FA Community Shield as manager as Arsenal beat Chelsea 4–1 on penalties following a 1–1 score at full time. However, in the 2017–18 FA Cup, Arsenal lost to Nottingham Forest in the third round of the FA Cup, and again stood well outside the top four in the Premier League. The club also dealt with player unrest in the form of Sánchez, who voiced his desire to depart, and Wenger sanctioned a transfer to Manchester United in January 2018, whereby Arsenal received Henrikh Mkhitaryan in a swap-deal. Later that month, he signed Pierre-Emerick Aubameyang for a club-record fee of £56 million. However, these additions did not aid Arsenal's performances as a team, and on 20 April, Wenger announced he would step down as Arsenal manager at the end of the 2017–18 season. His final home game was a 5–0 win against Burnley on 6 May, where he received a standing ovation before the game and was gifted the gold mini-replica Premier League trophy he won during the 2003–04 Invincibles season as a departing gift from Arsenal. He officially concluded his tenure with a 1–0 away win against Huddersfield Town. Wenger later revealed that he wanted to stay at the club until the expiration of his contract, but the club thought it better he leave, with the board informing him in January of their decision to end his contract at the end of the season.
Sources: en.wikipedia.org
Also in 2005, United States and India signed a ten-year defense framework agreement, with the goal of expanding bilateral security cooperation. The two countries engaged in numerous and unprecedented combined military exercises, and major US arms sales to India were concluded. An Open Skies Agreement was signed in April 2005, enhancing trade, tourism, and business via the increased number of flights, and Air India purchased 68 US Boeing aircraft at a cost of $8 billion. The United States and India also signed a bilateral Agreement on Science and Technology Cooperation in 2005. After Hurricane Katrina, India donated $5 million to the American Red Cross and sent two planeloads of relief supplies and materials to help. Then, on 1 March 2006, President Bush made another diplomatic visit to further expand relations between India and the U.S. The value of all bilateral trade tripled from 2004 to 2008 and continued to grow, while significant two-way investment also grows and flourishes. The political influence of a large Indian-American community is reflected in the largest country-specific caucus in the United States Congress, while between 2009 and 2010 more than 100,000 Indian students have attended American colleges and universities. In November 2010, President Barack Obama visited India and addressed a joint session of the Indian Parliament, where he backed India's bid for a permanent seat on the United Nations Security Council.
In anatomy and osteology, a foramen (; pl.: foramina, or foramens ; from Latin 'an opening produced by boring') is an opening or enclosed gap within the dense connective tissue (bones and deep fasciae) of extant and extinct amniote animals, typically to allow passage of nerves, arteries, veins or other soft tissue structures (e.g. muscle tendon) from one body compartment to another.
The IQOS is a heated tobacco product marketed by Philip Morris International. It heats tobacco at a lower temperature than traditional cigarettes. The tobacco sticks reach a temperature up to 350 °C. It sold first in Japan since November 2014. In December 2016, the United Tobacco Vapor Group's (UTVG) stated that they have been given a patent for their vaporizing component system. QMOS from UTVG does not contain a wick or sponge and the number of components is 5 compared to 20 for traditional e-cigarettes. Pax Labs has developed vaporizers that heats the leaves of tobacco to deliver nicotine in a vapor. In June 2015, they introduced Juul, a type of e-cigarette which delivers 10 times as much nicotine as other e-cigarettes, equivalent to an actual cigarette puff. Juul was spun off from Pax Labs in June 2017 and is now available by the independent company Juul Labs. The eTron 3T from Vapor Tobacco Manufacturing, launched in December 2014, employs a patented, aqueous system whereby the tobacco is extracted into water. The e-liquid contains organic tobacco, organic glycerin, and water. In December 2013, Japan Tobacco launched Ploom in Japan. In January 2016, they launched Ploom TECH that produces a vapor from a heated liquid that moves through a capsule of granulated tobacco leaves. In 2016, British American Tobacco (BAT) released its own version of the heat but not burn technology called glo in Japan and Switzerland. It uses tobacco sticks rather than nicotine liquid, and does not directly heat or burn tobacco.
In biological engineering, in situ describes experimental treatments applied to cells or tissues while they remain intact, rather than using extracts. It also refers to assays or manipulations performed on whole tissues without disrupting their natural structure. In biomedical engineering, in situ polymerization is used to produce protein nanogels, which serve as a versatile platform for the storage and release of therapeutic proteins. This approach has applications in cancer treatment, vaccination, diagnostics, regenerative medicine, and therapies for loss-of-function genetic diseases.
Sources: en.wikipedia.org
Multiple freezing and thawing events can cause aggregation, precipitation, or loss of soluble peptide. Dividing a solution into single-use aliquots before freezing reduces this risk. If multiple cycles are unavoidable, stability should be checked after thawing.
Low-binding polypropylene tubes are often used because some peptides adsorb to glass or standard plastic. The choice depends on peptide hydrophobicity and charge. Containers should be clean, sterile when needed, and compatible with the solvent.
Reverse-phase chromatography can assess purity and retention time, while mass spectrometry confirms molecular mass. These methods can detect degradation products and sequence-related impurities. Results are compared with a reference sample or initial analysis.
Allow the sealed vial to reach room temperature before opening to reduce condensation. Use a suitable solvent and gentle mixing rather than vigorous agitation. Follow the supplier's solubility information when available.